A detailed history of Arizona State Retirement System transactions in Lyell Immunopharma, Inc. stock. As of the latest transaction made, Arizona State Retirement System holds 36,704 shares of LYEL stock, worth $22,389. This represents 0.0% of its overall portfolio holdings.

Number of Shares
36,704
Previous 35,567 3.2%
Holding current value
$22,389
Previous $51,000 1.96%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$1.13 - $1.88 $1,284 - $2,137
1,137 Added 3.2%
36,704 $50,000
Q2 2024

Aug 05, 2024

BUY
$1.3 - $3.01 $1,244 - $2,880
957 Added 2.77%
35,567 $51,000
Q1 2024

May 07, 2024

SELL
$1.71 - $3.07 $815 - $1,464
-477 Reduced 1.36%
34,610 $77,000
Q4 2023

Jan 24, 2024

SELL
$1.39 - $2.35 $622 - $1,052
-448 Reduced 1.26%
35,087 $68,000
Q3 2023

Nov 06, 2023

BUY
$1.45 - $3.35 $696 - $1,608
480 Added 1.37%
35,535 $52,000
Q2 2023

Aug 01, 2023

BUY
$1.89 - $3.86 $66,253 - $135,312
35,055 New
35,055 $111,000

Others Institutions Holding LYEL

About Lyell Immunopharma, Inc.


  • Ticker LYEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 247,824,992
  • Market Cap $151M
  • Description
  • Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate...
More about LYEL
Track This Portfolio

Track Arizona State Retirement System Portfolio

Follow Arizona State Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Arizona State Retirement System with notifications on news.